257 related articles for article (PubMed ID: 24798974)
1. Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?
Byrne JA; Frost S; Chen Y; Bright RK
Tumour Biol; 2014 Aug; 35(8):7369-82. PubMed ID: 24798974
[TBL] [Abstract][Full Text] [Related]
2. Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer.
Byrne JA; Balleine RL; Schoenberg Fejzo M; Mercieca J; Chiew YE; Livnat Y; St Heaps L; Peters GB; Byth K; Karlan BY; Slamon DJ; Harnett P; Defazio A
Int J Cancer; 2005 Dec; 117(6):1049-54. PubMed ID: 15986428
[TBL] [Abstract][Full Text] [Related]
3. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.
Rubin MA; Varambally S; Beroukhim R; Tomlins SA; Rhodes DR; Paris PL; Hofer MD; Storz-Schweizer M; Kuefer R; Fletcher JA; Hsi BL; Byrne JA; Pienta KJ; Collins C; Sellers WR; Chinnaiyan AM
Cancer Res; 2004 Jun; 64(11):3814-22. PubMed ID: 15172988
[TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.
Ummanni R; Teller S; Junker H; Zimmermann U; Venz S; Scharf C; Giebel J; Walther R
FEBS J; 2008 Nov; 275(22):5703-13. PubMed ID: 18959755
[TBL] [Abstract][Full Text] [Related]
6. PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer.
Wang R; Xu J; Saramäki O; Visakorpi T; Sutherland WM; Zhou J; Sen B; Lim SD; Mabjeesh N; Amin M; Dong JT; Petros JA; Nelson PS; Marshall FF; Zhau HE; Chung LW
Cancer Res; 2004 Mar; 64(5):1589-94. PubMed ID: 14996714
[TBL] [Abstract][Full Text] [Related]
7. Tumor protein D52 (isoform 3) interacts with and promotes peroxidase activity of Peroxiredoxin 1 in prostate cancer cells implicated in cell growth and migration.
Dasari C; Reddy KRK; Natani S; Murthy TRL; Bhukya S; Ummanni R
Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1298-1309. PubMed ID: 30981892
[TBL] [Abstract][Full Text] [Related]
8. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of MicroRNA-449 Promotes Migration and Invasion of Breast Cancer Cells by Targeting Tumor Protein D52 (TPD52).
Zhang Z; Wang J; Gao R; Yang X; Zhang Y; Li J; Zhang J; Zhao X; Xi C; Lu X
Oncol Res; 2017 May; 25(5):753-761. PubMed ID: 27983918
[TBL] [Abstract][Full Text] [Related]
10. Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells.
Dasari C; Yaghnam DP; Walther R; Ummanni R
Tumour Biol; 2017 May; 39(5):1010428317698382. PubMed ID: 28466782
[TBL] [Abstract][Full Text] [Related]
11. microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.
Han G; Fan M; Zhang X
Biochem Biophys Res Commun; 2015 Jan; 456(3):804-9. PubMed ID: 25511701
[TBL] [Abstract][Full Text] [Related]
12. TPD52 is a Potential Prognostic Biomarker and Correlated with Immune Infiltration: A Pan-cancer Analysis.
Miao L; Jing L; Chen B; Zeng T; Chen Y
Curr Mol Med; 2023 Oct; ():. PubMed ID: 38178662
[TBL] [Abstract][Full Text] [Related]
13. Tumor protein D52 overexpression and gene amplification in cancers from a mosaic of microarrays.
Shehata M; Weidenhofer J; Thamotharampillai K; Hardy JR; Byrne JA
Crit Rev Oncog; 2008; 14(1):33-55. PubMed ID: 19105569
[TBL] [Abstract][Full Text] [Related]
14. Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway.
Zhao Z; Liu H; Hou J; Li T; Du X; Zhao X; Xu W; Xu W; Chang J
Oncol Res; 2017 May; 25(5):773-779. PubMed ID: 27983909
[TBL] [Abstract][Full Text] [Related]
15. TPD52 represents a survival factor in ERBB2-amplified breast cancer cells.
Roslan N; Bièche I; Bright RK; Lidereau R; Chen Y; Byrne JA
Mol Carcinog; 2014 Oct; 53(10):807-19. PubMed ID: 23661506
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑103a‑3p promotes metastasis by targeting TPD52 in salivary adenoid cystic carcinoma.
Fu M; Chen CW; Yang LQ; Yang WW; Du ZH; Li YR; Li SL; Ge XY
Int J Oncol; 2020 Aug; 57(2):574-586. PubMed ID: 32467999
[TBL] [Abstract][Full Text] [Related]
17. Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR.
Tennstedt P; Bölch C; Strobel G; Minner S; Burkhardt L; Grob T; Masser S; Sauter G; Schlomm T; Simon R
Int J Oncol; 2014 Feb; 44(2):609-15. PubMed ID: 24317684
[TBL] [Abstract][Full Text] [Related]
18. Tumor protein D52 (TPD52) affects cancer cell metabolism by negatively regulating AMPK.
Chen Y; Peng C; Tan W; Yu J; Zayas J; Peng Y; Lou Z; Pei H; Wang L
Cancer Med; 2023 Jan; 12(1):488-499. PubMed ID: 35666017
[TBL] [Abstract][Full Text] [Related]
19. MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.
Byrne JA; Maleki S; Hardy JR; Gloss BS; Murali R; Scurry JP; Fanayan S; Emmanuel C; Hacker NF; Sutherland RL; Defazio A; O'Brien PM
BMC Cancer; 2010 Sep; 10():497. PubMed ID: 20846453
[TBL] [Abstract][Full Text] [Related]
20. Tumor protein D52 expression is post-transcriptionally regulated by T-cell intercellular antigen (TIA) 1 and TIA-related protein via mRNA stability.
Motohashi H; Mukudai Y; Ito C; Kato K; Shimane T; Kondo S; Shirota T
Biochem J; 2017 May; 474(10):1669-1687. PubMed ID: 28298474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
